Discontinued Operations The summary of the assets and liabilities related to Pharmaceutical Manufacturing- China discontinued operations (Details) (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012 Pharmaceutical Manufacturing - China business [Member]	Dec. 31, 2011 Pharmaceutical Manufacturing - China business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	$ 10,789,480	$ 1,548,351	$ 10,789,500	$ 8,707,000
Restricted cash			2,892,400	0
Accounts receivable, net			7,105,300	5,525,700
Inventory			15,141,900	16,505,700
Deferred income taxes			344,200	463,700
Prepaid expenses and other current assets			750,900	777,500
Property, plant and equipment, net			37,327,300	36,490,400
Land use rights, net			3,021,500	4,872,400
Goodwill			0	8,495,700
Intangible assets, net			0	21,846,400
Other assets			2,821,100	2,459,900
Total assets			80,194,100	106,144,400
Accounts Payable			8,730,500	7,950,300
Accrued liabilities			2,874,700	1,705,800
Bank loans			17,369,000	15,712,000
Notes payable			6,541,300	0
Income tax payable			2,142,300	621,600
Deferred income taxes			5,902,400	6,177,400
Unearned revenue			1,544,100	1,315,400
Amount due related parties			8,519,200	20,862,700
Total Liabilities			$ 53,623,500	$ 54,345,200